Birgitte Grønkær Toft

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Biopsy 55%
3. Prostatectomy 55%
4. Testicular Neoplasms 55%
5. Penile Neoplasms 48%
6. Neoplasms 37%
7. Carcinoma in Situ 30%
8. Denmark 30%
9. Germ Cells 29%
10. Seminoma 26%
11. Testicular Germ Cell Tumor 24%
12. Neoplasm Grading 23%
13. Prostate-Specific Antigen 23%
14. Urinary Bladder 19%
15. Germ Cell and Embryonal Neoplasms 18%
16. Recurrence 17%
17. Testis 16%
18. Cystoscopy 16%
19. Cohort Studies 15%
20. Lymph Nodes 15%
21. Margins of Excision 15%
22. Population 15%
23. Pheochromocytoma 15%
24. Groin 14%
25. Databases 14%
26. Prostate 14%
27. Positron Emission Tomography Computed Tomography 14%
28. Pathology 13%
29. Smoking Cessation 13%
30. Sporadic Papillary renal cell carcinoma 13%
31. proneuropeptide Y 13%
32. Mortality 12%
33. Castration 12%
34. Urinary Bladder Neoplasms 12%
35. Tobacco Use Cessation Devices 12%
36. Urethral Neoplasms 11%
37. Watchful Waiting 11%
38. Smokers 11%
39. Renal Cell Carcinoma 10%
40. Neoplasm Metastasis 10%
41. Systematized Nomenclature of Medicine 10%
42. LH Receptors 10%
43. Cystoscopes 10%
44. Therapeutics 10%
45. Natural Killer Cells 10%
46. Sex Cord-Gonadal Stromal Tumors 10%
47. Carcinoma 10%
48. Needle Biopsy 10%
49. Randomized Controlled Trials 10%
50. 5-hydroxymethylcytosine 10%